Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 358.85
+7.10 (2.02%)
At close: Jul 31, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 39.1 billion as of July 31, 2026. Its market cap has decreased by -7.60% in one year.
Market Cap
39.10B
Enterprise Value
40.66B
Revenue
1.66B
Ranking
n/a
PE Ratio
83.84
Stock Price
358.85
ChartMarket Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 39.10B, an increase of 112,262.88%. That is a compound annual growth rate of 33.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 39.10B | -18.89% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 246.55B |
| Shilpa Medicare | 118.05B |
| Suven Life Sciences | 79.01B |
| IOL Chemicals and Pharmaceuticals | 42.36B |
| Sai Parenteral's | 23.63B |
| NGL Fine-Chem | 20.22B |
| Bajaj HealthCare | 11.05B |
| Shree Ganesh Remedies | 8.40B |